Evidence map›Paper›PMID 26482736›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2016

Minocycline exacerbates apoptotic neurodegeneration induced by the NMDA receptor antagonist MK-801 in the early postnatal mouse brain.

Ioana Inta, Miriam A Vogt, Anne S Vogel, Markus Bettendorf, Peter Gass, Dragos Inta

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ioana IntaDivision of Pediatric Endocrinology, University Children's Hospital Heidelberg, Heidelberg, Germany.
Miriam A VogtDepartment of Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute for Mental Health Mannheim, University of Heidelberg, Heidelberg, Germany.
Anne S VogelDepartment of Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute for Mental Health Mannheim, University of Heidelberg, Heidelberg, Germany.
Markus BettendorfDivision of Pediatric Endocrinology, University Children's Hospital Heidelberg, Heidelberg, Germany.
Peter GassDepartment of Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute for Mental Health Mannheim, University of Heidelberg, Heidelberg, Germany.
Dragos IntaDepartment of Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute for Mental Health Mannheim, University of Heidelberg, Heidelberg, Germany. Dragos.Inta@zi-mannheim.de.
Heidelberg University · DECentral Institute of Mental Health · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NMDA receptor (NMDAR) antagonists induce in perinatal rodent cortical apoptosis and protracted schizophrenia-like alterations ameliorated by antipsychotic treatment. The broad-spectrum antibiotic minocycline elicits antipsychotic and neuroprotective effects. Here we tested, if minocycline protects also against apoptosis triggered by the NMDAR antagonist MK-801 at postnatal day 7. Surprisingly, minocycline induced widespread cortical apoptosis and exacerbated MK-801-triggered cell death. In some areas such as the subiculum, the pro-apoptotic effect of minocycline was even more pronounced than that elicited by MK-801. These data reveal among antipsychotics unique pro-apoptotic properties of minocycline, raising concerns regarding consequences for brain development and the use in children.

Indexed as

AnimalsAnti-Bacterial AgentsApoptosisBrainDisease Models, AnimalDizocilpine MaleateExcitatory Amino Acid AntagonistsMiceMice, Inbred C57BLMinocyclineNeuronsNeuroprotective AgentsReceptors, N-Methyl-D-AspartateAnti-Bacterial AgentsDizocilpine MaleateExcitatory Amino Acid AntagonistsMinocyclineNeuroprotective AgentsReceptors, N-Methyl-D-AspartateCaspase-3MinocyclineMK-801NeurodevelopmentNeurotoxicitySchizophrenia

Identifiers

PMID26482736
OpenAlexW2253366143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.